CO4970838A1 - USE OF AZOL DERIVATIVES FOR THE PREPARATION OF A DERMATOLOGICAL OR COSMETOLOGICAL COMPOSITION - Google Patents

USE OF AZOL DERIVATIVES FOR THE PREPARATION OF A DERMATOLOGICAL OR COSMETOLOGICAL COMPOSITION

Info

Publication number
CO4970838A1
CO4970838A1 CO98060041A CO98060041A CO4970838A1 CO 4970838 A1 CO4970838 A1 CO 4970838A1 CO 98060041 A CO98060041 A CO 98060041A CO 98060041 A CO98060041 A CO 98060041A CO 4970838 A1 CO4970838 A1 CO 4970838A1
Authority
CO
Colombia
Prior art keywords
preparation
dermatological
composition
cosmetological composition
omoconazole
Prior art date
Application number
CO98060041A
Other languages
Spanish (es)
Inventor
Gerd Ries
Dominique Castelli
Original Assignee
Roc Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roc Sa filed Critical Roc Sa
Publication of CO4970838A1 publication Critical patent/CO4970838A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole

Abstract

La presente invención se relaciona con el uso de almenosun derivado de azol seleccionado de un grupo formado por bifonazol, butoconazol, clordantoina, clormidazol, cloconazol, clotrimazol, econazol, enilconazol, fenticonazol, flutrimazol, isoconazol, cetoconazol, lanoconazol, miconazol, omoconazol, oxiconazol, sertaconazol, sulconazol, tioconazol, elubiol y derivados del triazol, para la preparación de una composición para combatir los efectos de los radicales libres.The present invention relates to the use of at least one azole derivative selected from a group consisting of bifonazole, butoconazole, chlordantoin, chlorormidazole, cloconazole, clotrimazole, econazole, enilconazole, fenticonazole, flutrimazole, isoconazole, ketoconazole, lanoconazole, miconazole, omoconazole, omoconazole , sertaconazole, sulconazole, thioconazole, elubiol and triazole derivatives, for the preparation of a composition to combat the effects of free radicals.

CO98060041A 1997-10-16 1998-10-15 USE OF AZOL DERIVATIVES FOR THE PREPARATION OF A DERMATOLOGICAL OR COSMETOLOGICAL COMPOSITION CO4970838A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9712951A FR2769838B1 (en) 1997-10-16 1997-10-16 USE OF NITROGEN DERIVATIVES FOR THE PREPARATION OF A DERMATOLOGICAL OR COSMETOLOGICAL COMPOSITION

Publications (1)

Publication Number Publication Date
CO4970838A1 true CO4970838A1 (en) 2000-11-07

Family

ID=9512294

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98060041A CO4970838A1 (en) 1997-10-16 1998-10-15 USE OF AZOL DERIVATIVES FOR THE PREPARATION OF A DERMATOLOGICAL OR COSMETOLOGICAL COMPOSITION

Country Status (4)

Country Link
AU (1) AU9278598A (en)
CO (1) CO4970838A1 (en)
FR (1) FR2769838B1 (en)
WO (1) WO1999020271A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19938404A1 (en) * 1999-08-13 2001-02-22 Clariant Gmbh Cosmetic preparations
US20050201965A1 (en) * 2004-03-11 2005-09-15 The Procter & Gamble Company Personal cleansing compositions
WO2006004795A2 (en) * 2004-06-25 2006-01-12 The Johns Hopkins University Angiogenesis inhibitors
US20060142304A1 (en) * 2004-12-27 2006-06-29 Michael Southall Method for treating or preventing pruritic and neurogenic skin disorders
JP6194003B2 (en) 2012-10-09 2017-09-06 ザ プロクター アンド ギャンブル カンパニー Method for identifying or evaluating beneficial agent and composition containing the same
CN104703585A (en) 2012-10-09 2015-06-10 宝洁公司 Method of identifying synergistic cosmetic combinations
US9138393B2 (en) 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
US9144538B2 (en) 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin
EP3897624A1 (en) * 2018-12-17 2021-10-27 Institut National de la Santé et de la Recherche Médicale (INSERM) Use of sulconazole as a furin inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210840A (en) * 1984-01-18 1987-05-29 Johnson & Johnson Baby Prod Composition comprising synergistic combination of miconazole nitrate and zinc oxide
ZA887662B (en) * 1987-10-19 1989-06-28 Merrell Dow Pharma Method for reducing reperfusion injury with imidazol-2-thione-carboxamides
FR2711990B1 (en) * 1993-11-05 1995-12-08 Exsymol Sa Pseudodipeptide product having an imidazole group, and therapeutic, cosmetological and agrifood applications.
FR2714380B1 (en) * 1993-12-24 1996-05-24 Bioxytech Use of 2-mercapto-imidazole derivatives substituted in position 4 (or 5) as antioxidants, their preparation process and their applications in pharmacy, cosmetics or food.

Also Published As

Publication number Publication date
WO1999020271A1 (en) 1999-04-29
FR2769838A1 (en) 1999-04-23
FR2769838B1 (en) 2000-04-07
AU9278598A (en) 1999-05-10

Similar Documents

Publication Publication Date Title
CO4970838A1 (en) USE OF AZOL DERIVATIVES FOR THE PREPARATION OF A DERMATOLOGICAL OR COSMETOLOGICAL COMPOSITION
BR0112725A (en) Antimicotic Nail Polish Composition
RU2326881C2 (en) Condensed derivatives of azolpyrimine with inhibiting properties of phosphatidyl inositol-3-kinase (pi3k)
DE60134874D1 (en) BENZODIAZEPINE DERIVATIVES AS GAMMA-SECRETASE INHIBITORS
AR053331A1 (en) COMBINED THERAPY
BR0307802A (en) Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, production processes and their use
PT2179987E (en) Use of heterocyclic carbaldehyde derivatives against sickle cell anemia
AP2001002066A0 (en) Substituted oxazoles and thiazoles derivatives at hPPAR gamma and hPPAR alpha activators
SE9503143D0 (en) New preparation
KR970706002A (en) Use of Aromatase Inhibitors in the Preparation of a Drug for Relative Androgen Deficiency in Men in the Preparation of a Medicament for the Treatment of Relative Androgen Deficiency in Male
BRPI0510110A (en) method for treating, preventing or controlling pulmonary hypertension, and pharmaceutical composition
PL311204A1 (en) Indole derivatives as antagonists of 5-ht-like receptors for use in hemicrania
RU2006129637A (en) VAGINAL COMPOSITIONS FOR TREATING INFECTIONS
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
ES2185660T3 (en) NEW USE OF DEXMEDETOMIDINE.
MX2008013040A (en) Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands.
BR9916268A (en) Pesticide concentrates in aqueous suspension
NO953371L (en) Use of anti-convulsants in the treatment of neuro-AIDS
BRPI0418623A (en) pharmaceutical composition and packaging
EA200001010A1 (en) APPLICATION OF DEXMEDETOMIDINE FOR SEDATIVE IMPACT IN THE DEPARTMENT OF INTENSIVE THERAPY
HUP0100680A2 (en) Indole derivatives and medicinal compositions containing the same
RU2004131859A (en) HEATING AND NON-IRRITANT LUBRICANT ANTI-FUNGAL GELEOFIC COMPOSITIONS
RS11104A (en) Combined preparations,containing 1,4- benzothiepine-1,1- dioxide derivatives and other active substances, and the use thereof
AR001834A1 (en) Use of a combination of active products in the manufacture of the leather, microbicidal agent containing said active products, procedure for the protection of animal skins and leather against microbial attack, use of this combination to obtain agents
BRPI0411954A (en) nanoparticles of polyoxyethylene derivatives and their method of preparation